Skip to content

Dr. Steven Heireman

Active
Private limited companyfounded 2016active for 10 yearsSchaapsdreef(Kor) 32, 8500 Kortrijk, BelgiumKBO/BCE: BE 0650.846.640
Summary

Dr. Steven Heireman has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €18,600 and a net result of €464,767. Equity has been stable since 2018 (±1.7% per year). Its solvency ranks better than 9% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 29-03-2016 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment units
2.251.897.065 8500 Kortrijk, since 29-03-2016
2.251.897.164 8550 Zwevegem, since 29-03-2016
Financial year end
31 December
Peppol
Reachable since 03-04-2025

Board and ownership

Board
  • Heireman StevenDirector

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€666,156
▲ 9.7%
Turnover
≈ €1.0m
estimated
Profit
€464,767
▲ 10.9%
Equity
€18,600
=
Total assets
€524,577
▼ 6.8%
Score breakdownraises riskEquity €18,600 (3.5% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €524,577Figures for financial year 2025 (filed on 13-07-2026)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 33% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 29+1
equity 3.5% of total assets
Liquidity 32+3
short-term debt 95.0% · cash 25.8%
Profitability 100=
return on assets 88.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: 0.1%▲ +0.1 percentage points vs 06-2026highest value 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.04 (1.05 in 2024), below the usual 1.5. Short-term debt is 95% and cash 25.8% of total assets. 96.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 9% of them on solvency, 6% on liquidity, 80% on profitability and 37% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €524,577
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €18,600 (3.5% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 13-07-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 9% of 20700 sector peers (2025).
NBB · sector comparison
Position among 20700 sector peers
Solvency
better than 9%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
18 days early
2024
24 days early
2023
22 days early
2022
7 days early
2021
29 days late
2020
29 days early
2019
24 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 14 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 91% of companies in human healthsector median 63.0% · 20,700 companies 3.5% View
  • Positive: 8 profitable years in a rowprofit 2025: €464,767 8 years View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

Recent changes

  1. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as Dr. Steven Heireman: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €492,000 and €548,000, founded between 2015 and 2017.

CompanyTotal assetsGross margin
Dr. Steven Heireman Kortrijk€524,577€666,156
Dr. A. Vanden Bulcke Roeselare€514,747€617,580
Dr. Caroline VENSTERMANS Edegem€514,364€645,952
MED COSTE NEUPREZ Liège€523,646€698,592
DRS. CAEKEBEKE EN D'HAESE Antwerpen€492,037€683,211
DRGH Lanaken€541,032€717,517
Dr. Anne-Sophie Vliegen - Radioloog Hasselt€548,254€603,727
Full comparison

Key facts about Dr. Steven Heireman

What is the company number of Dr. Steven Heireman?
The company number of Dr. Steven Heireman is 0650.846.640. The VAT number is the same number with BE in front: BE 0650.846.640.
Where is Dr. Steven Heireman based?
The registered office is at Schaapsdreef(Kor) 32, 8500 Kortrijk.Company details
What does Dr. Steven Heireman do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Steven Heireman?
The legal form of Dr. Steven Heireman is Private limited company (BV).
When was Dr. Steven Heireman founded?
Dr. Steven Heireman was founded on 29-03-2016.
Is Dr. Steven Heireman still active?
Yes, Dr. Steven Heireman is an active enterprise in the KBO register.
What is the turnover of Dr. Steven Heireman?
The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €666,156 and 36 comparable companies (NACE 862). It probably lies between €920,000 and €1.3m.Financials
Is Dr. Steven Heireman profitable?
In financial year 2025, Dr. Steven Heireman made a profit of €464,767.
Where can I find the annual accounts of Dr. Steven Heireman?
Dr. Steven Heireman filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Steven Heireman due?
Dr. Steven Heireman must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.